Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontranscription factor binding

NFYA NCOA2 NFAT5 CREBBP YAP1 COMMD7

1.63e-05753166GO:0008134
GeneOntologyMolecularFunctiontranscription coregulator activity

NCOA2 BCL9L CREBBP YAP1 TAF15

5.86e-05562165GO:0003712
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

NFYA NCOA2 NFAT5 TARDBP CREBBP YAP1 ZFHX3

6.96e-051459167GO:0000977
GeneOntologyMolecularFunctiontranscription coactivator activity

NCOA2 BCL9L CREBBP YAP1

8.19e-05303164GO:0003713
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

NCOA2 BCL9L TARDBP CREBBP YAP1 TAF15

1.83e-041160166GO:0030674
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

NFYA NCOA2 NFAT5 TARDBP YAP1 ZFHX3

2.69e-041244166GO:0000978
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

NFYA NCOA2 NFAT5 TARDBP YAP1 ZFHX3

3.02e-041271166GO:0000987
GeneOntologyMolecularFunctionmolecular adaptor activity

NCOA2 BCL9L TARDBP CREBBP YAP1 TAF15

4.29e-041356166GO:0060090
GeneOntologyMolecularFunctionDNA-binding transcription factor binding

NCOA2 CREBBP YAP1 COMMD7

9.83e-04582164GO:0140297
GeneOntologyMolecularFunctionchromatin binding

NCOA2 NFAT5 CREBBP YAP1

2.37e-03739164GO:0003682
GeneOntologyMolecularFunctionRNA polymerase II-specific DNA-binding transcription factor binding

NCOA2 CREBBP COMMD7

4.14e-03417163GO:0061629
GeneOntologyMolecularFunctiontranscription coregulator binding

NFYA CREBBP

5.49e-03140162GO:0001221
GeneOntologyBiologicalProcessrhythmic process

NFYA NCOA2 TARDBP CREBBP ZFHX3

5.87e-06360165GO:0048511
GeneOntologyBiologicalProcesspositive regulation of transcription by RNA polymerase II

NFYA NCOA2 NFAT5 BCL9L CREBBP YAP1 ZFHX3

4.14e-051390167GO:0045944
GeneOntologyBiologicalProcesspositive regulation of protein localization to nucleus

TARDBP CREBBP YAP1

8.74e-05114163GO:1900182
GeneOntologyBiologicalProcessresponse to transforming growth factor beta

BCL9L CREBBP ZFHX3 TNRC6C

1.17e-04343164GO:0071559
GeneOntologyBiologicalProcesslocomotor rhythm

NCOA2 ZFHX3

1.29e-0422162GO:0045475
GeneOntologyBiologicalProcessprotein localization to nucleus

TARDBP CREBBP YAP1 AGAP3

1.44e-04362164GO:0034504
GeneOntologyBiologicalProcesscellular response to abiotic stimulus

NFAT5 CREBBP YAP1 AGAP3

1.58e-04371164GO:0071214
GeneOntologyBiologicalProcesscellular response to environmental stimulus

NFAT5 CREBBP YAP1 AGAP3

1.58e-04371164GO:0104004
GeneOntologyBiologicalProcessregulation of protein localization to nucleus

TARDBP CREBBP YAP1

3.15e-04176163GO:1900180
GeneOntologyBiologicalProcesscellular response to radiation

CREBBP YAP1 AGAP3

4.19e-04194163GO:0071478
GeneOntologyBiologicalProcessresponse to progesterone

NCOA2 YAP1

5.48e-0445162GO:0032570
GeneOntologyBiologicalProcessstem cell population maintenance

BCL9L CREBBP YAP1

7.51e-04237163GO:0019827
GeneOntologyBiologicalProcessmaintenance of cell number

BCL9L CREBBP YAP1

7.98e-04242163GO:0098727
GeneOntologyBiologicalProcesscircadian rhythm

NCOA2 TARDBP ZFHX3

8.57e-04248163GO:0007623
GeneOntologyBiologicalProcessprotein localization to organelle

TARDBP CREBBP YAP1 BNIP3L AGAP3

1.10e-031091165GO:0033365
GeneOntologyBiologicalProcesstransforming growth factor beta receptor signaling pathway

BCL9L CREBBP TNRC6C

1.17e-03276163GO:0007179
GeneOntologyBiologicalProcesscircadian behavior

NCOA2 ZFHX3

1.36e-0371162GO:0048512
GeneOntologyBiologicalProcessregulation of mRNA stability

TARDBP TAF15 TNRC6C

1.37e-03292163GO:0043488
GeneOntologyBiologicalProcessrhythmic behavior

NCOA2 ZFHX3

1.47e-0374162GO:0007622
GeneOntologyBiologicalProcesscircadian regulation of gene expression

NCOA2 ZFHX3

1.51e-0375162GO:0032922
GeneOntologyBiologicalProcessmRNA stabilization

TARDBP TAF15

1.60e-0377162GO:0048255
GeneOntologyBiologicalProcessregulation of RNA stability

TARDBP TAF15 TNRC6C

1.60e-03308163GO:0043487
GeneOntologyBiologicalProcessregulation of mRNA catabolic process

TARDBP TAF15 TNRC6C

1.61e-03309163GO:0061013
GeneOntologyCellularComponenttranscription regulator complex

NFYA NCOA2 NFAT5 BCL9L CREBBP YAP1 ZFHX3

1.35e-07596167GO:0005667
GeneOntologyCellularComponentRNA polymerase II transcription regulator complex

NFYA NCOA2 BCL9L CREBBP YAP1

1.40e-06272165GO:0090575
GeneOntologyCellularComponentnuclear body

NCOA2 TARDBP CREBBP ZFHX3 BNIP3L AGAP3

3.52e-05903166GO:0016604
GeneOntologyCellularComponentchromatin

NFYA NCOA2 NFAT5 TARDBP CREBBP ZFHX3

5.38e-041480166GO:0000785
GeneOntologyCellularComponentcytoplasmic ribonucleoprotein granule

TARDBP PRRC2C TNRC6C

1.04e-03269163GO:0036464
GeneOntologyCellularComponentribonucleoprotein granule

TARDBP PRRC2C TNRC6C

1.26e-03287163GO:0035770
GeneOntologyCellularComponentcytoplasmic stress granule

TARDBP PRRC2C

2.40e-0396162GO:0010494
GeneOntologyCellularComponentnuclear protein-containing complex

NFYA NCOA2 BCL9L CREBBP YAP1

2.91e-031377165GO:0140513
GeneOntologyCellularComponentPML body

CREBBP AGAP3

4.03e-03125162GO:0016605
DomainNuc_rcpt_coact

NCOA2 CREBBP

1.03e-056162IPR009110
DomainRRM_1

TARDBP TAF15 TNRC6C

6.85e-04208163PF00076
DomainRRM

TARDBP TAF15 TNRC6C

7.75e-04217163SM00360
DomainRRM_dom

TARDBP TAF15 TNRC6C

8.83e-04227163IPR000504
DomainRRM

TARDBP TAF15 TNRC6C

9.17e-04230163PS50102
Domain-

TARDBP TAF15 TNRC6C

1.09e-032441633.30.70.330
DomainNucleotide-bd_a/b_plait

TARDBP TAF15 TNRC6C

1.28e-03258163IPR012677
PathwayREACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP

NFYA NCOA2 CREBBP

1.09e-0542153M27172
PathwayREACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF

NFYA NCOA2 CREBBP

2.47e-0555153M27001
PathwayREACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES

NFYA CREBBP

1.26e-0416152M27940
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3

CREBBP YAP1 ZFHX3

1.31e-0496153M27784
PathwayREACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA

CREBBP YAP1

1.42e-0417152M48025
PathwayREACTOME_RORA_ACTIVATES_GENE_EXPRESSION

NCOA2 CREBBP

1.60e-0418152M26942
PathwayREACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE

CREBBP BNIP3L

1.99e-0420152M27628
PathwayREACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA

NFYA NCOA2 CREBBP

2.42e-04118153M27316
PathwayREACTOME_RNA_POLYMERASE_II_TRANSCRIPTION

NFYA CREBBP YAP1 ZFHX3 TAF15 BNIP3L TNRC6C

2.78e-041387157M734
PathwayREACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION

NCOA2 CREBBP

3.65e-0427152M26943
PathwayPID_P53_DOWNSTREAM_PATHWAY

NFYA CREBBP BNIP3L

3.75e-04137153M145
PathwayPID_RETINOIC_ACID_PATHWAY

NCOA2 CREBBP

4.52e-0430152M207
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53

CREBBP TAF15 BNIP3L TNRC6C

4.57e-04360154M27267
PathwayREACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION

NCOA2 CREBBP TNRC6C

4.80e-04149153M27888
PathwayREACTOME_METABOLISM_OF_STEROIDS

NFYA NCOA2 CREBBP

5.28e-04154153M27832
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4

CREBBP TNRC6C

5.81e-0434152M46422
PathwayREACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES

CREBBP BNIP3L

9.74e-0444152M27499
PathwayREACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS

NCOA2 CREBBP

9.74e-0444152M27295
PathwayREACTOME_HEME_SIGNALING

NCOA2 CREBBP

1.21e-0349152M41832
PathwayPID_AR_TF_PATHWAY

NCOA2 CREBBP

1.41e-0353152M151
PathwayREACTOME_ESR_MEDIATED_SIGNALING

NCOA2 CREBBP TNRC6C

1.49e-03220153M27794
PathwayREACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS

NCOA2 CREBBP

1.52e-0355152M27145
PathwayREACTOME_CYTOPROTECTION_BY_HMOX1

NCOA2 CREBBP

1.81e-0360152M41830
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1

CREBBP YAP1 TNRC6C

1.84e-03237153M27786
PathwayPID_HIF1_TFPATHWAY

NCOA2 CREBBP

2.18e-0366152M255
PathwayREACTOME_FOXO_MEDIATED_TRANSCRIPTION

NFYA CREBBP

2.18e-0366152M27938
PathwayREACTOME_CIRCADIAN_CLOCK

NCOA2 CREBBP

2.45e-0370152M938
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3

YAP1 ZFHX3

2.88e-0376152MM15520
PathwayPID_REG_GR_PATHWAY

NCOA2 CREBBP

3.34e-0382152M115
PathwayPID_SMAD2_3NUCLEAR_PATHWAY

NCOA2 CREBBP

3.34e-0382152M2
PathwayREACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS

NCOA2 CREBBP TNRC6C

3.46e-03296153M27869
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION

NCOA2 CREBBP

3.50e-0384152M1008
PathwayPID_CMYB_PATHWAY

CREBBP ZFHX3

3.50e-0384152M195
PathwayREACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX

BCL9L CREBBP

4.10e-0391152M27101
PathwayWP_ANDROGEN_RECEPTOR_SIGNALING

NCOA2 CREBBP

4.10e-0391152M39700
PathwayREACTOME_SIGNALING_BY_ALK_IN_CANCER

TNRC6C RRBP1

4.28e-0393152M42521
PathwayREACTOME_MITOCHONDRIAL_BIOGENESIS

NCOA2 CREBBP

4.55e-0396152M26973
PathwayREACTOME_SIGNALING_BY_WNT

BCL9L CREBBP TNRC6C

4.69e-03330153M7847
PathwayWP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY

NFYA CREBBP

5.02e-03101152MM15829
PathwayWP_WNT_SIGNALING_AND_PLURIPOTENCY

NFYA CREBBP

5.02e-03101152M39387
PathwayREACTOME_ADIPOGENESIS

NCOA2 CREBBP

5.93e-03110152M48259
PathwayREACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING

CREBBP TNRC6C

6.91e-03119152M607
PathwayREACTOME_GENERIC_TRANSCRIPTION_PATHWAY

YAP1 ZFHX3 TAF15 BNIP3L

7.36e-03768154MM14851
PathwayREACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT

CREBBP YAP1

7.95e-03128152M48019
PathwayREACTOME_GASTRULATION

CREBBP YAP1

8.07e-03129152M46433
Pubmed

Human transcription factor protein interaction networks.

NFYA NCOA2 BCL9L TARDBP CREBBP YAP1 PRRC2C ZFHX3 TNRC6C

2.87e-09142916935140242
Pubmed

EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation.

NCOA2 CREBBP

1.19e-06416215987788
Pubmed

MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.

NCOA2 CREBBP

1.19e-06416216613851
Pubmed

Genetic association of a polymorphism of the cAMP-responsive element binding protein-binding protein with steroid-induced osteonecrosis after kidney transplantation.

NCOA2 CREBBP

1.19e-06416217704997
Pubmed

MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.

NCOA2 CREBBP

1.19e-06416217697320
Pubmed

A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies.

NCOA2 CREBBP

1.19e-06416211583620
Pubmed

Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.

TARDBP TAF15

1.19e-06416225062688
Pubmed

Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses.

TARDBP TAF15

1.98e-06516227378374
Pubmed

Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.

NCOA2 CREBBP

1.98e-06516214766010
Pubmed

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.

CREBBP BNIP3L

1.98e-06516215607964
Pubmed

MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.

NCOA2 CREBBP

1.98e-06516215657427
Pubmed

p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor.

NCOA2 CREBBP

1.98e-06516212810069
Pubmed

CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor.

NCOA2 CREBBP

1.98e-06516217932106
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

NCOA2 NFAT5 CREBBP ZFHX3 TNRC6C AGAP3 RRBP1

2.12e-06148916728611215
Pubmed

Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.

CREBBP TAF15

2.97e-06616218509338
Pubmed

A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy.

NFYA CREBBP

2.97e-06616223908595
Pubmed

The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

NCOA2 CREBBP

2.97e-0661629430642
Pubmed

The hnRNP RALY regulates PRMT1 expression and interacts with the ALS-linked protein FUS: implication for reciprocal cellular localization.

TARDBP TAF15

2.97e-06616230354839
Pubmed

Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.

NCOA2 CREBBP

2.97e-06616215731352
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

NCOA2 TARDBP CREBBP YAP1 PRRC2C

3.64e-0654916538280479
Pubmed

Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.

NCOA2 CREBBP

4.16e-0671629590696
Pubmed

BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.

NCOA2 CREBBP

4.16e-06716216860316
Pubmed

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.

NCOA2 CREBBP

4.16e-0671629192892
Pubmed

A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.

CREBBP YAP1

4.16e-06716216332960
Pubmed

Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase.

NCOA2 CREBBP

5.55e-06816211971985
Pubmed

Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.

NCOA2 CREBBP

5.55e-06816210490106
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

NCOA2 BCL9L CREBBP YAP1

5.83e-0626816433640491
Pubmed

CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1.

YAP1 TAF15

1.09e-051116235989368
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

BCL9L TARDBP CREBBP PRRC2C

1.36e-0533216437433992
Pubmed

Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.

TARDBP PRRC2C TAF15 TNRC6C RRBP1

1.40e-0572516527025967
Pubmed

Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140.

NCOA2 CREBBP

1.54e-051316211266503
Pubmed

Interaction network of human early embryonic transcription factors.

NCOA2 BCL9L CREBBP ZFHX3

1.69e-0535116438297188
Pubmed

Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.

NCOA2 CREBBP

1.80e-051416212482968
Pubmed

Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.

NCOA2 CREBBP

2.69e-051716219183483
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

NFYA NCOA2 CREBBP PRRC2C RRBP1

3.13e-0585716525609649
Pubmed

T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.

NCOA2 CREBBP

3.75e-052016211877444
Pubmed

Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.

NCOA2 CREBBP

4.15e-052116219596656
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

NCOA2 CREBBP TNRC6C

4.40e-0515216338360978
Pubmed

Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.

NCOA2 BCL9L CREBBP PRRC2C

4.72e-0545716432344865
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

TARDBP CREBBP YAP1 TAF15 RRBP1

6.97e-05101416532416067
Pubmed

Increased gene copy number of VAMP7 disrupts human male urogenital development through altered estrogen action.

NCOA2 CREBBP

7.45e-052816224880616
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

TARDBP PRRC2C TAF15 RRBP1

9.75e-0555116434728620
Pubmed

Amyotrophic Lateral Sclerosis Overview

TARDBP TAF15

1.04e-043316220301623
Pubmed

Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes.

BCL9L CREBBP

1.10e-043416230894540
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

BCL9L PRRC2C KCNA4 AGAP3 RRBP1

1.21e-04113916536417873
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

NCOA2 CREBBP YAP1 PRRC2C

1.25e-0458816438580884
Pubmed

TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.

NCOA2 TARDBP ZFHX3

1.32e-0422016335785414
Pubmed

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.

TARDBP PRRC2C RRBP1

1.37e-0422316320020773
Pubmed

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.

NFAT5 TARDBP YAP1 RRBP1

1.59e-0462616433644029
Pubmed

The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety.

NFYA NCOA2

1.77e-044316226487511
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

NFAT5 TARDBP YAP1 TAF15 RRBP1

1.84e-04124716527684187
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

TARDBP PRRC2C TAF15 RRBP1

1.89e-0465516435819319
Pubmed

A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.

TARDBP TAF15

1.94e-044516225496916
Pubmed

A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.

NCOA2 NFAT5 CREBBP ZFHX3

2.56e-0470916422988430
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

TARDBP ZFHX3 TAF15

2.76e-0428316330585729
Pubmed

Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.

TARDBP PRRC2C RRBP1

3.12e-0429516326209609
Pubmed

New nomenclature for chromatin-modifying enzymes.

NCOA2 CREBBP

3.12e-045716218022353
Pubmed

Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization.

NCOA2 CREBBP

3.12e-045716224952745
Pubmed

High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.

CREBBP TNRC6C AGAP3

3.50e-0430716337499664
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

TARDBP ZFHX3 TAF15 AGAP3

3.63e-0477716435844135
Pubmed

A global genomic transcriptional code associated with CNS-expressed genes.

NCOA2 TARDBP ZFHX3

3.88e-0431816316919269
Pubmed

Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.

NCOA2 CREBBP

4.06e-046516223319000
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

TARDBP PRRC2C TAF15 RRBP1

4.19e-0480716422681889
Pubmed

Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.

NFYA NCOA2 NFAT5 ZFHX3

4.21e-0480816420412781
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

NFAT5 TARDBP TAF15 RRBP1

4.23e-0480916432129710
Pubmed

Tagging genes with cassette-exchange sites.

CREBBP YAP1 PRRC2C

4.52e-0433516315741177
InteractionAR interactions

NCOA2 BCL9L TARDBP CREBBP YAP1 ZFHX3 TAF15

5.30e-06992167int:AR
InteractionTLE3 interactions

NCOA2 BCL9L CREBBP ZFHX3 TAF15

8.12e-06376165int:TLE3
InteractionEGR2 interactions

NCOA2 BCL9L CREBBP ZFHX3

8.41e-06171164int:EGR2
InteractionYAP1 interactions

NFAT5 BCL9L TARDBP CREBBP YAP1 PRRC2C RRBP1

1.02e-051095167int:YAP1
InteractionNKX2-1 interactions

NCOA2 CREBBP ZFHX3 TAF15

1.03e-05180164int:NKX2-1
InteractionHSPB1 interactions

TARDBP CREBBP YAP1 PRRC2C TAF15 AGAP3

1.09e-05708166int:HSPB1
InteractionHNF1B interactions

NCOA2 CREBBP YAP1 ZFHX3

1.27e-05190164int:HNF1B
InteractionNR5A1 interactions

NFYA NCOA2 CREBBP

1.37e-0560163int:NR5A1
InteractionKLF5 interactions

NCOA2 CREBBP YAP1 RRBP1

1.41e-05195164int:KLF5
InteractionFEV interactions

NCOA2 CREBBP YAP1 ZFHX3

1.65e-05203164int:FEV
InteractionCNOT3 interactions

CREBBP PRRC2C TNRC6C AGAP3

1.79e-05207164int:CNOT3
InteractionJUN interactions

NFYA NCOA2 NFAT5 CREBBP YAP1

2.39e-05470165int:JUN
InteractionTARDBP interactions

TARDBP YAP1 PRRC2C TAF15 RRBP1

3.87e-05520165int:TARDBP
InteractionTBP interactions

NFYA TARDBP CREBBP TAF15

3.92e-05253164int:TBP
InteractionCRX interactions

NCOA2 BCL9L CREBBP ZFHX3

3.98e-05254164int:CRX
InteractionCEP55 interactions

YAP1 TAF15 TNRC6C RRBP1

4.10e-05256164int:CEP55
InteractionHELZ interactions

TARDBP CREBBP PRRC2C TNRC6C

4.17e-05257164int:HELZ
InteractionGSC interactions

BCL9L CREBBP ZFHX3

4.18e-0587163int:GSC
InteractionEWSR1 interactions

BCL9L TARDBP CREBBP TAF15 BNIP3L RRBP1

4.41e-05906166int:EWSR1
InteractionMED23 interactions

NCOA2 CREBBP YAP1 ZFHX3

4.77e-05266164int:MED23
InteractionZHX1 interactions

NFYA TARDBP CREBBP

4.78e-0591163int:ZHX1
InteractionXRCC6 interactions

NFYA TARDBP CREBBP YAP1 ZFHX3 TAF15

5.05e-05928166int:XRCC6
InteractionPML interactions

NCOA2 TARDBP CREBBP YAP1 AGAP3 RRBP1

5.20e-05933166int:PML
InteractionPIAS3 interactions

NCOA2 CREBBP ZFHX3

5.44e-0595163int:PIAS3
InteractionTPR interactions

YAP1 PRRC2C TAF15 RRBP1

5.90e-05281164int:TPR
InteractionKIF5A interactions

NCOA2 CREBBP YAP1

5.96e-0598163int:KIF5A
InteractionPOU2F3 interactions

CREBBP YAP1

6.17e-0515162int:POU2F3
InteractionCELF1 interactions

TARDBP PRRC2C TAF15 TNRC6C

6.49e-05288164int:CELF1
InteractionPRRC2C interactions

TARDBP YAP1 PRRC2C RRBP1

6.67e-05290164int:PRRC2C
InteractionKLF15 interactions

NCOA2 CREBBP YAP1 PRRC2C

6.67e-05290164int:KLF15
InteractionHCFC1 interactions

YAP1 PRRC2C TAF15 RRBP1

6.94e-05293164int:HCFC1
InteractionCREBBP interactions

NFYA NCOA2 CREBBP YAP1 BNIP3L

7.59e-05599165int:CREBBP
InteractionTP63 interactions

NFYA TARDBP YAP1 COMMD7

8.01e-05304164int:TP63
InteractionFLNB interactions

TARDBP YAP1 PRRC2C RRBP1

8.01e-05304164int:FLNB
InteractionCTNNB1 interactions

NFYA NCOA2 BCL9L TARDBP CREBBP YAP1

8.06e-051009166int:CTNNB1
InteractionYTHDF2 interactions

TARDBP CREBBP PRRC2C TNRC6C

8.85e-05312164int:YTHDF2
InteractionBAG2 interactions

NCOA2 TARDBP CREBBP YAP1 PRRC2C

9.07e-05622165int:BAG2
InteractionTBR1 interactions

NCOA2 BCL9L ZFHX3

9.11e-05113163int:TBR1
InteractionAHNAK interactions

TARDBP YAP1 PRRC2C RRBP1

9.53e-05318164int:AHNAK
InteractionLDB1 interactions

BCL9L TARDBP ZFHX3

9.60e-05115163int:LDB1
InteractionTBXT interactions

NCOA2 CREBBP YAP1

9.85e-05116163int:TBXT
InteractionFBL interactions

TARDBP YAP1 PRRC2C TAF15 RRBP1

1.03e-04639165int:FBL
InteractionPOU3F2 interactions

NFYA YAP1

1.11e-0420162int:POU3F2
InteractionDDX3X interactions

TARDBP CREBBP YAP1 PRRC2C TAF15

1.12e-04651165int:DDX3X
InteractionBMI1 interactions

TARDBP CREBBP PRRC2C TAF15 RRBP1

1.19e-04659165int:BMI1
InteractionRRBP1 interactions

TARDBP YAP1 PRRC2C RRBP1

1.25e-04341164int:RRBP1
InteractionSRCAP interactions

NCOA2 CREBBP YAP1

1.29e-04127163int:SRCAP
InteractionWDR5 interactions

TARDBP CREBBP YAP1 PRRC2C TAF15 RRBP1

1.31e-041101166int:WDR5
InteractionPAX9 interactions

NCOA2 BCL9L ZFHX3

1.38e-04130163int:PAX9
InteractionCDK9 interactions

TARDBP CREBBP PRRC2C TAF15 RRBP1

1.43e-04685165int:CDK9
InteractionPHB1 interactions

TARDBP YAP1 PRRC2C TAF15 TNRC6C RRBP1

1.46e-041123166int:PHB1
InteractionPABPC1 interactions

TARDBP YAP1 PRRC2C TAF15 TNRC6C

1.57e-04699165int:PABPC1
InteractionHNRNPDL interactions

TARDBP PRRC2C TAF15 RRBP1

1.60e-04364164int:HNRNPDL
InteractionRACK1 interactions

TARDBP YAP1 PRRC2C TNRC6C RRBP1

1.63e-04704165int:RACK1
InteractionDDX21 interactions

NFAT5 TARDBP YAP1 PRRC2C TAF15

1.78e-04718165int:DDX21
InteractionNCOA6 interactions

NCOA2 CREBBP YAP1

1.91e-04145163int:NCOA6
InteractionMEX3A interactions

BCL9L TARDBP CREBBP PRRC2C

1.97e-04384164int:MEX3A
InteractionPRRC2A interactions

TARDBP YAP1 PRRC2C TNRC6C

2.07e-04389164int:PRRC2A
InteractionTBK1 interactions

NCOA2 YAP1 PRRC2C TNRC6C

2.35e-04402164int:TBK1
InteractionEEF1A1 interactions

TARDBP CREBBP YAP1 PRRC2C RRBP1

2.35e-04762165int:EEF1A1
InteractionSOX6 interactions

NCOA2 PRRC2C ZFHX3

2.41e-04157163int:SOX6
InteractionNFE2L2 interactions

NFAT5 CREBBP TAF15

2.50e-04159163int:NFE2L2
InteractionBRCA1 interactions

NFYA NCOA2 TARDBP CREBBP TAF15 TNRC6C

2.61e-041249166int:BRCA1
InteractionWWTR1 interactions

NCOA2 CREBBP YAP1 PRRC2C

2.82e-04422164int:WWTR1
InteractionDSP interactions

TARDBP YAP1 TNRC6C RRBP1

2.85e-04423164int:DSP
InteractionNUP35 interactions

NCOA2 BCL9L CREBBP PRRC2C

2.88e-04424164int:NUP35
InteractionDDX17 interactions

TARDBP CREBBP YAP1 TAF15

2.93e-04426164int:DDX17
InteractionTRERF1 interactions

CREBBP YAP1

3.08e-0433162int:TRERF1
InteractionHSPA2 interactions

NCOA2 YAP1 PRRC2C RRBP1

3.31e-04440164int:HSPA2
InteractionLATS1 interactions

CREBBP YAP1 TAF15 TNRC6C

3.31e-04440164int:LATS1
InteractionTLX1 interactions

NCOA2 CREBBP ZFHX3

3.32e-04175163int:TLX1
InteractionPABPC4 interactions

TARDBP TAF15 TNRC6C RRBP1

3.37e-04442164int:PABPC4
InteractionTEAD1 interactions

CREBBP YAP1 ZFHX3

3.37e-04176163int:TEAD1
InteractionCNOT2 interactions

PRRC2C ZFHX3 TNRC6C

3.49e-04178163int:CNOT2
InteractionH3-4 interactions

NCOA2 CREBBP PRRC2C TAF15

3.55e-04448164int:H3-4
InteractionSNRNP200 interactions

TARDBP CREBBP YAP1 TAF15

3.92e-04460164int:SNRNP200
InteractionSMARCA4 interactions

CREBBP YAP1 TAF15 RRBP1

3.99e-04462164int:SMARCA4
InteractionNFAT5 interactions

NFAT5 YAP1

4.09e-0438162int:NFAT5
InteractionRORA interactions

NCOA2 CREBBP

4.30e-0439162int:RORA
InteractionJUP interactions

NFYA TARDBP CREBBP YAP1

4.79e-04485164int:JUP
InteractionRELA interactions

CREBBP YAP1 ZFHX3 COMMD7

4.79e-04485164int:RELA
InteractionUSP14 interactions

CREBBP YAP1 TAF15 RRBP1

4.94e-04489164int:USP14
InteractionH3C1 interactions

CREBBP PRRC2C ZFHX3 TAF15 RRBP1

5.11e-04901165int:H3C1
InteractionSOX2 interactions

NCOA2 BCL9L TARDBP YAP1 ZFHX3 TAF15

5.28e-041422166int:SOX2
InteractionDDX6 interactions

TARDBP YAP1 PRRC2C RRBP1

5.50e-04503164int:DDX6
InteractionMTDH interactions

TARDBP CREBBP AGAP3 RRBP1

5.58e-04505164int:MTDH
InteractionGMEB1 interactions

NCOA2 CREBBP

5.74e-0445162int:GMEB1
InteractionPRMT1 interactions

NCOA2 TARDBP PRRC2C TAF15 RRBP1

5.88e-04929165int:PRMT1
InteractionCHD4 interactions

YAP1 PRRC2C ZFHX3 TAF15 RRBP1

6.14e-04938165int:CHD4
InteractionBCL9L interactions

BCL9L YAP1

6.53e-0448162int:BCL9L
InteractionPYGO2 interactions

BCL9L CREBBP

6.53e-0448162int:PYGO2
InteractionNR1I2 interactions

NCOA2 YAP1

6.53e-0448162int:NR1I2
InteractionPOLR2A interactions

NFYA CREBBP YAP1 TAF15

6.98e-04536164int:POLR2A
InteractionTGM1 interactions

CREBBP YAP1 TAF15

7.18e-04228163int:TGM1
InteractionTAF11 interactions

NFYA TAF15

7.37e-0451162int:TAF11
InteractionEID1 interactions

NCOA2 CREBBP

7.37e-0451162int:EID1
InteractionIKBKB interactions

CREBBP BNIP3L COMMD7

7.64e-04233163int:IKBKB
InteractionCASP8AP2 interactions

CREBBP BNIP3L

7.66e-0452162int:CASP8AP2
InteractionPLS3 interactions

YAP1 PRRC2C RRBP1

8.03e-04237163int:PLS3
InteractionSFPQ interactions

TARDBP YAP1 PRRC2C TAF15

8.39e-04563164int:SFPQ
CytobandEnsembl 112 genes in cytogenetic band chr16q22

NFAT5 ZFHX3

1.83e-03183162chr16q22
GeneFamilyZinc fingers ZZ-type|Lysine acetyltransferases

NCOA2 CREBBP

3.73e-0517102486
GeneFamilyRNA binding motif containing

TARDBP TAF15

5.84e-03213102725
CoexpressionTABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING

NFAT5 TARDBP PRRC2C ZFHX3 RRBP1

2.85e-06394165MM3724
CoexpressionGSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN

NCOA2 NFAT5 TARDBP TAF15

5.25e-06197164M4421
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

NCOA2 CREBBP YAP1 PRRC2C ZFHX3 TAF15

7.21e-06856166M4500
CoexpressionLAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM

CREBBP PRRC2C BNIP3L TNRC6C

9.88e-05417164M39224
CoexpressionLAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB

NCOA2 NFAT5 YAP1

1.39e-04169163M39230
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN

NFYA CREBBP PRRC2C ZFHX3

1.53e-04467164M1347
CoexpressionGSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP

BCL9L CREBBP PRRC2C

1.54e-04175163M8908
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

NFAT5 CREBBP PRRC2C

1.67e-04180163M8239
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN

NFYA CREBBP PRRC2C ZFHX3

1.75e-04484164MM999
CoexpressionTABULA_MURIS_SENIS_LUNG_ALVEOLAR_MACROPHAGE_AGEING

PRRC2C ZFHX3 RRBP1

1.84e-04186163MM3762
CoexpressionGSE22886_CD8_VS_CD4_NAIVE_TCELL_DN

NCOA2 CREBBP TAF15

2.15e-04196163M4404
CoexpressionGSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP

ZFHX3 TAF15 RRBP1

2.18e-04197163M8983
CoexpressionGSE22886_NAIVE_TCELL_VS_NKCELL_DN

NCOA2 NFAT5 TARDBP

2.21e-04198163M4415
CoexpressionGSE360_DC_VS_MAC_DN

NFYA ZFHX3 RRBP1

2.21e-04198163M5173
CoexpressionGAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS

YAP1 ZFHX3 RRBP1

2.24e-04199163M43608
CoexpressionGSE31082_DN_VS_CD4_SP_THYMOCYTE_DN

NFAT5 CREBBP BNIP3L

2.28e-04200163M5059
CoexpressionGSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN

NFYA TARDBP AGAP3

2.28e-04200163M3823
CoexpressionRICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP

NFYA TNRC6C COMMD7

3.98e-04242163M904
CoexpressionHOUNKPE_HOUSEKEEPING_GENES

TARDBP CREBBP BNIP3L AGAP3 COMMD7

4.31e-041129165M42508
CoexpressionHOUNKPE_HOUSEKEEPING_GENES

TARDBP CREBBP BNIP3L AGAP3 COMMD7

4.85e-041158165MM1338
CoexpressionIKEDA_MIR1_TARGETS_UP

NFAT5 RRBP1

4.91e-0454162MM927
CoexpressionIKEDA_MIR1_TARGETS_UP

NFAT5 RRBP1

4.91e-0454162M2372
CoexpressionBILBAN_B_CLL_LPL_UP

BNIP3L RRBP1

6.89e-0464162M19930
CoexpressionQI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE

CREBBP BNIP3L RRBP1

7.02e-04294163M40873
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000

NFAT5 PRRC2C TAF15 TNRC6C

1.47e-04375164gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500

NFAT5 ZFHX3 TNRC6C KCNA4

1.71e-04390164gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

NCOA2 NFAT5 CREBBP

3.74e-0518616303db813598b67b1e08f759758a1c2023396921fa
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

NFAT5 PRRC2C RRBP1

4.18e-05193163e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellfacs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C ZFHX3 RRBP1

4.31e-05195163a1478021a3ed0e779716393124ca2a7770c433b7
ToppCellCOVID-19_Mild-Neu_0|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients

NFYA ZFHX3

2.29e-04631621ab77b6f098686bc168427159282bbf3538d4292
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ZFHX3 RRBP1

6.34e-041051628f31edf4183587f5b53941475453c5aa49f10bbd
ToppCell356C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

NCOA2 BCL9L

1.11e-03139162b9c2dfab119ac0efdf931bb2910e82bccdb4e48d
ToppCell356C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

NCOA2 BCL9L

1.11e-03139162aefcfda2b2db302ce4b3d2a09f767be0b1c3ac6c
ToppCellBAL-Control-cDC_4|Control / Compartment, Disease Groups and Clusters

TARDBP ZFHX3

1.20e-031451623b2a2965dc18abd39d5ed70c0fcad0210e7f12c8
ToppCelldroplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFHX3 BNIP3L

1.46e-03160162822adcf5f9208f305cafffd8ed97f3a061e82b03
ToppCellCD8+_Memory_T_cell-RSV-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

ZFHX3 BNIP3L

1.48e-03161162f6d04f67da3557e80f13ef27bfabb94dcd80db2f
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 KCNA4

1.50e-03162162f1851a173d3bcca2981d934161ec85d1cc0af5a2
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 KCNA4

1.50e-03162162c7114e24cb5525abb9780ca3d35dbcc4eabd4b64
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 KCNA4

1.50e-031621625d902bb31e691aea9749617cc88303c2448f24b8
ToppCelldroplet-Marrow-BM-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFHX3 BNIP3L

1.50e-0316216276e289ad9fd3694f77fd0d19e74c1cb8e87b8094
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFHX3 BNIP3L

1.55e-031651629acf03b5a20170721380045b5c268825e8f315dd
ToppCellfacs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCL9L ZFHX3

1.59e-031671627f3224af9b30082b927a822b91f96e0c88151b4e
ToppCellfacs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCL9L ZFHX3

1.59e-03167162a21a2b301d0a3d7a41e605f7a3c37548962a331d
ToppCellfacs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCL9L ZFHX3

1.59e-031671620e746483773bde6582874a33591ab2a578d724eb
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class

NFAT5 AGAP3

1.61e-03168162ea465152ea31391b63c02425beafa9a4f51f6703
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

BNIP3L KCNA4

1.64e-0317016274bb46826141bd1e80b4ce16e6bbfc770bd427d3
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

BNIP3L KCNA4

1.64e-031701626592ebe204b43b81c6b6da99e05da72c0983b3fa
ToppCellfacs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BCL9L ZFHX3

1.64e-03170162b4f2c05db2c2591561fd42febc72eed3b5e8f9fb
ToppCellLV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper

YAP1 ZFHX3

1.66e-03171162e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCellCOVID-19_Severe-NK_CD56bright|COVID-19_Severe / Disease condition and Cell class

ZFHX3 RRBP1

1.66e-031711625810f790012a0750ca3378595514f66a99f123be
ToppCelldroplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZFHX3 BNIP3L

1.68e-03172162d354424c1f861b6607dfd63b9724f4c237b30275
ToppCellfacs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

YAP1 RRBP1

1.68e-0317216265b8935a972bf00b7a10dc2d442128fc0ed78bcb
ToppCellfacs-Marrow-B-cells-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

YAP1 RRBP1

1.68e-03172162a7fd4d61fb5017dce001d69d6b9a01e6cdf58828
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.70e-031731620672bd8a4a9d18af343d01f09253fb3388896c10
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.70e-03173162869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class

NFAT5 AGAP3

1.70e-03173162502f888b7684ed39f5c577eedcacf673ae81d39e
ToppCellfacs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.70e-03173162870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCellfacs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.74e-031751621ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCelldroplet-Marrow-BM_(NON-STC)-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.80e-031781621a578d16008a450c42e73a996247ffecdc2c43f0
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

BNIP3L AGAP3

1.82e-031791626624a2e731ab2d6c2eec19445e3dc509f581a8a9
ToppCellLA-01._Fibroblast_I|LA / Chamber and Cluster_Paper

ZFHX3 BNIP3L

1.82e-03179162dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCelldroplet-Marrow-BM-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

YAP1 RRBP1

1.86e-03181162c7d12c7de227c9433ec2303b8929e957b833f59b
ToppCelldroplet-Marrow-BM-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

YAP1 RRBP1

1.86e-03181162cd46eba2e03fd15d8de8e875793ae2f51fa98b3b
ToppCelldroplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.88e-03182162bc8d621be57f76d718d9b0f11e023b0f4dcb668d
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells)

KCNA4 AGAP3

1.92e-03184162cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells)

KCNA4 AGAP3

1.92e-03184162bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.92e-031841621154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellpdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

NFAT5 YAP1

1.94e-031851621d874608aa2062024323512f68889219471b2f00
ToppCelldroplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

1.94e-031851627adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell3'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TARDBP COMMD7

1.96e-03186162e265aac37f33947ff6c83f23f8a2c63bbccd60af
ToppCellpdx|World / Sample and Cell Type and Tumor Cluster (all cells)

NFAT5 YAP1

1.96e-03186162de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

PRRC2C ZFHX3

1.96e-0318616223b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellpdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

NFAT5 YAP1

1.96e-031861620b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCellsaliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

BCL9L YAP1

1.98e-0318716243ef900b76f3c38bd8ce9858201124130c743d56
ToppCelldroplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CREBBP PRRC2C

1.98e-03187162663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCellsaliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

BCL9L YAP1

1.98e-031871626e5c38425b6b1d4774f8dcea7e146f1eab785c3e
ToppCellLA-01._Fibroblast_I|World / Chamber and Cluster_Paper

ZFHX3 BNIP3L

1.98e-031871624ea486991f66c29728d127171a07b81404ec0b78
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 KCNA4

2.03e-03189162032f169e8ede653117919bf97c17f92043320b3c
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

BCL9L TNRC6C

2.03e-031891629ab77c6fcb573854da5922412f53d2168bda6b58
ToppCellrenal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

NCOA2 NFAT5

2.03e-03189162830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NFAT5 YAP1

2.03e-0318916290aae7e806882bebfad78a78e9a16cf56af3ecd4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

BCL9L TNRC6C

2.03e-031891625a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCellrenal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

PRRC2C BNIP3L

2.03e-03189162a48df46274d51e84ffb40264646de7346104efb9
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ZFHX3 KCNA4

2.03e-0318916207208d32afca6f93207a2ac35b647b31a9f71b7c
ToppCellLV-01._Fibroblast_I|World / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.05e-0319016212992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCellLV-02._Fibroblast_II|World / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.07e-03191162d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCellRV-01._Fibroblast_I|World / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.07e-0319116270c067c54084bfb02c29bab085f4defd477194fb
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

2.09e-0319216211088878043a6ff95ba1970361256a82e434b80a
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

NFAT5 RRBP1

2.09e-03192162916fbec1c7ab7969bda711886ac88e877e30c280
ToppCellRV-01._Fibroblast_I|RV / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.09e-03192162356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZFHX3 KCNA4

2.11e-031931627631bf3362b4fa061ffeab4879ab12c4708dc4c0
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

2.11e-0319316206b65110db974f4ef90d3511ff34428976a52c9c
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.11e-03193162dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

2.11e-031931629c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZFHX3 KCNA4

2.11e-031931628d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571
ToppCellfacs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

2.11e-03193162a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCellControl-NK_CD56bright|Control / Disease condition and Cell class

ZFHX3 RRBP1

2.11e-031931628b1e7a226a6057e1097c1525984127b54e823876
ToppCellfacs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

2.11e-03193162b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCellLA|World / Chamber and Cluster_Paper

ZFHX3 RRBP1

2.11e-03193162d4bf89437216baf489ea0239136dcedf3b6714af
ToppCellnucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NCOA2 NFAT5

2.11e-03193162779276e775cb2492e8dd36436295a536084a6415
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

BCL9L TNRC6C

2.11e-03193162792315f409a57fa6a8a88c850060b1e089e062ea
ToppCell368C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NFAT5 BNIP3L

2.13e-03194162f9b9cbd1a418a7cbd151c2425fda6b864db9aa82
ToppCellLV-02._Fibroblast_II|LV / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.13e-03194162014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

NFAT5 YAP1

2.13e-03194162abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

NFAT5 YAP1

2.13e-0319416246070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCellRV-02._Fibroblast_II|RV / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.13e-0319416211c79a8c56ece42713b04b321982e41e239f07a5
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

2.13e-03194162e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCellLA-02._Fibroblast_II|LA / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.13e-03194162234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell368C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NFAT5 BNIP3L

2.15e-031951628da933942e9033e18e25ab47831c269747b1c0b2
ToppCellRV-02._Fibroblast_II|World / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.15e-03195162ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PRRC2C RRBP1

2.15e-031951625c86fddd6d0530beecf45ea5ba6b823123847696
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.15e-03195162a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCellRA-02._Fibroblast_II|RA / Chamber and Cluster_Paper

ZFHX3 BNIP3L

2.15e-031951626a02ebbeb3199447ddce64d92d8809436e040eba
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

NCOA2 YAP1

2.18e-03196162ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellCOVID-19_Severe|World / Disease condition and Cell class

PRRC2C TAF15

2.18e-03196162450ac2aff89c5ca73b8bfbc80663e03be066931f
ToppCellVE-NK|VE / Condition, Cell_class and T cell subcluster

ZFHX3 RRBP1

2.20e-03197162cae6ff8763501e7a5897b50188ac2640d65a47c0
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

BCL9L TNRC6C

2.20e-0319716259b1fb93a39dcf8c994d2b7dc2906dae74c57527
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

PRRC2C RRBP1

2.20e-031971620fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellVE-NK-|VE / Condition, Cell_class and T cell subcluster

ZFHX3 RRBP1

2.20e-03197162ee89b8521fb4faaed9e4d39f7171e45eccf38b00
ToppCellPCW_10-12|World / Celltypes from embryonic and fetal-stage human lung

NFAT5 BNIP3L

2.20e-0319716247fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCell3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRRC2C RRBP1

2.22e-031981627ad7726fc405806b1d7824f58548073ea5e0c70b
ToppCell3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRRC2C RRBP1

2.22e-031981621fbec311f2c987ca90a023a5989128c05aa12d5c
ToppCell10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

YAP1 RRBP1

2.22e-031981629d61483b0decac2fe90045b3474843360b2c49b3
ToppCell3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRRC2C RRBP1

2.22e-031981624f26a60e99f42343e5af7221723e108a1a1b7827
ToppCell3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PRRC2C RRBP1

2.22e-03198162ceede961ad9af6a3159db7efaa5087bf38aafc2d
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

NCOA2 YAP1

2.22e-031981621996373bdccc55aac347d349bd22f6aad6d0c668
DrugMF101 extract

NCOA2 CREBBP

4.62e-065162ctd:C517398
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

NCOA2 CREBBP YAP1 ZFHX3

5.09e-061701641050_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1 ZFHX3

5.46e-061731643243_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA

NCOA2 CREBBP YAP1 ZFHX3

5.71e-061751641058_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1 ZFHX3

5.84e-061761643312_DN
Drugtrichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA

NCOA2 CREBBP YAP1 ZFHX3

5.84e-06176164981_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1 ZFHX3

5.97e-061771646434_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

NCOA2 CREBBP YAP1 ZFHX3

6.11e-061781641112_DN
DrugFlunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A

NCOA2 NFAT5 TAF15 RRBP1

8.07e-061911644303_DN
DrugCapsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A

NFYA ZFHX3 TAF15 RRBP1

8.58e-061941644612_DN
DrugHydroflumethiazide [135-09-1]; Up 200; 12uM; MCF7; HT_HG-U133A

NFYA NCOA2 BNIP3L RRBP1

8.94e-061961641687_UP
DrugPyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A

ZFHX3 TAF15 BNIP3L RRBP1

9.12e-061971647171_DN
DrugTrichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A

NFYA NFAT5 TAF15 RRBP1

9.30e-061981641797_DN
DrugPhenol

NFYA NCOA2 TARDBP

9.87e-05131163ctd:D019800
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP RRBP1

1.88e-041631637453_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP ZFHX3

1.95e-041651632835_DN
DrugDigoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A

NFYA NFAT5 RRBP1

1.99e-041661633283_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

1.99e-041661632268_DN
Drugpyrethrin

NCOA2 BNIP3L

2.13e-0431162CID000011442
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

NCOA2 YAP1 ZFHX3

2.13e-041701637043_DN
DrugBisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A

NFYA NFAT5 RRBP1

2.17e-041711633297_UP
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

NCOA2 CREBBP TAF15

2.17e-041711631234_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

NCOA2 CREBBP ZFHX3

2.21e-041721636439_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP ZFHX3

2.21e-041721632330_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.21e-041721631637_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

NCOA2 CREBBP ZFHX3

2.21e-041721631072_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.24e-041731635987_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.28e-041741633462_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.28e-041741631659_DN
Druggeldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA

NFYA ZFHX3 RRBP1

2.28e-04174163972_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.28e-041741635693_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.32e-041751637236_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.36e-041761631535_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP ZFHX3

2.36e-041761636784_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.40e-041771631645_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.40e-041771633177_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

NCOA2 CREBBP TAF15

2.44e-04178163992_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

NCOA2 CREBBP YAP1

2.48e-041791634483_DN
Drugglutamin

NFAT5 TARDBP CREBBP AGAP3

2.49e-04461164CID000000738
DrugDigoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A

NFYA NFAT5 RRBP1

2.52e-041801633397_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP ZFHX3

2.52e-041801636454_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.52e-041801634821_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.56e-041811636951_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.56e-041811637005_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A

NFYA NCOA2 CREBBP

2.61e-041821633887_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.65e-041831634770_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A

NCOA2 CREBBP YAP1

2.69e-041841636939_DN
DrugCyproterone Acetate

NCOA2 CREBBP

2.72e-0435162ctd:D017373
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

NCOA2 CREBBP YAP1

2.73e-041851635882_DN
DrugProchlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A

NFYA NCOA2 RRBP1

2.78e-041861635010_DN
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

NFYA NFAT5 RRBP1

2.78e-041861633279_DN
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

NFAT5 PRRC2C RRBP1

2.87e-041881636735_DN
DrugFlupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A

NFAT5 PRRC2C TAF15

2.91e-041891631288_DN
DrugAmpyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A

NCOA2 NFAT5 PRRC2C

2.96e-041901634507_DN
DrugChlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; PC3; HT_HG-U133A

NFYA TAF15 RRBP1

3.00e-041911632055_DN
DrugCorynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A

NFYA NFAT5 RRBP1

3.00e-041911634811_DN
DrugCyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A

NFAT5 PRRC2C RRBP1

3.05e-041921633252_DN
DrugErgocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A

NCOA2 ZFHX3 RRBP1

3.05e-041921632572_UP
DrugGliquidone [33342-05-1]; Up 200; 7.6uM; HL60; HT_HG-U133A

YAP1 ZFHX3 RRBP1

3.14e-041941633126_UP
DrugFlumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A

NFAT5 CREBBP TAF15

3.14e-041941634272_DN
DrugCephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A

NFYA NCOA2 NFAT5

3.19e-041951632517_DN
DrugTocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A

NFYA NCOA2 TAF15

3.19e-041951634961_DN
Drug5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA

NFAT5 CREBBP ZFHX3

3.19e-04195163843_DN
Drug5252917; Down 200; 14uM; MCF7; HT_HG-U133A_EA

NFAT5 BNIP3L RRBP1

3.19e-04195163828_DN
DrugAdenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A

NFYA NCOA2 NFAT5

3.19e-041951633237_DN
DrugLiothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A

NCOA2 TAF15 RRBP1

3.19e-041951634947_DN
DrugHippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; HL60; HT_HG-U133A

NCOA2 NFAT5 TAF15

3.19e-041951632187_DN
DrugCefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A

PRRC2C TAF15 RRBP1

3.19e-041951636159_DN
DrugChicago sky blue 6B [2610-05-1]; Down 200; 4uM; HL60; HT_HG-U133A

NCOA2 TAF15 RRBP1

3.19e-041951631330_DN
DrugChloramphenicol [56-75-7]; Down 200; 12.4uM; HL60; HT_HG-U133A

NCOA2 TAF15 RRBP1

3.19e-041951631837_DN
DrugPHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A

NFYA NCOA2 RRBP1

3.24e-041961636596_DN
DrugThalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A

NCOA2 NFAT5 PRRC2C

3.24e-041961632258_DN
DrugBenzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A

NFYA NCOA2 RRBP1

3.24e-041961633329_DN
DrugTolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A

NCOA2 NFAT5 RRBP1

3.24e-041961634844_DN
DrugCarisoprodol [78-44-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A

NCOA2 PRRC2C TAF15

3.24e-041961634955_DN
DrugGSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A

NFYA PRRC2C TAF15

3.24e-041961636559_UP
DrugDiclofenac sodium [15307-79-6]; Down 200; 12.6uM; PC3; HT_HG-U133A

NFYA NCOA2 TAF15

3.24e-041961635861_DN
DrugIsoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A

NCOA2 NFAT5 TAF15

3.24e-041961635812_DN
DrugGlutethimide, para-amino [125-84-8]; Down 200; 17.2uM; HL60; HT_HG-U133A

NFYA NFAT5 RRBP1

3.24e-041961632390_DN
DrugAmitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; HL60; HT_HG-U133A

NFYA NFAT5 TAF15

3.24e-041961631865_UP
DrugEstrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A

NFYA NFAT5 RRBP1

3.24e-041961634993_DN
DrugKetoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A

NFAT5 ZFHX3 RRBP1

3.29e-041971635685_DN
DrugPaclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT_HG-U133A

NFYA NCOA2 TAF15

3.29e-041971635320_DN
DrugKaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A

NFYA NCOA2 NFAT5

3.29e-041971633579_DN
Drugarachidonic acid sodium salt; Down 200; 10uM; MCF7; HG-U133A

NFYA BNIP3L RRBP1

3.29e-04197163441_DN
Drugaspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A

NFYA NCOA2 NFAT5

3.29e-041971635201_DN
DrugNapelline [5008-52-6]; Down 200; 11.2uM; HL60; HT_HG-U133A

NFYA NCOA2 RRBP1

3.29e-041971632522_DN
DrugPrilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; PC3; HT_HG-U133A

NFYA TAF15 RRBP1

3.29e-041971633727_UP
DrugIvermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A

NFAT5 TARDBP RRBP1

3.29e-041971637206_DN
DrugFusaric acid [536-69-6]; Down 200; 22.4uM; HL60; HT_HG-U133A

NFYA NFAT5 TAF15

3.29e-041971631308_DN
DrugNabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A

NFYA NCOA2 TAF15

3.29e-041971636487_DN
DrugAtropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A

NFYA NCOA2 NFAT5

3.29e-041971634476_DN
DrugCarbetapentane citrate [23142-01-0]; Up 200; 7.6uM; HL60; HT_HG-U133A

NFAT5 TAF15 RRBP1

3.34e-041981631268_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

NFYA NCOA2 YAP1

3.34e-041981633332_DN
DrugCefotiam hydrochloride; Down 200; 7.2uM; HL60; HT_HG-U133A

NFYA NFAT5 RRBP1

3.34e-041981632458_DN
Drug2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A

NFAT5 TAF15 RRBP1

3.34e-041981635219_DN
DrugChlorogenic acid [327-97-9]; Down 200; 11.2uM; HL60; HT_HG-U133A

NCOA2 TAF15 RRBP1

3.34e-041981631346_DN
Drugcolcemid; Down 200; 11.7uM; MCF7; HT_HG-U133A_EA

NFYA CREBBP TAF15

3.34e-041981631103_DN
DrugTheobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A

NFYA NFAT5 TAF15

3.34e-041981634958_DN
Drugchlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A

ZFHX3 TAF15 RRBP1

3.34e-041981634441_DN
Diseasefrontotemporal dementia (implicated_via_orthology)

TARDBP TAF15

1.81e-0512162DOID:9255 (implicated_via_orthology)
Diseasesuicidal ideation

NCOA2 ZFHX3

1.11e-0429162EFO_0004320
Diseaseamyotrophic lateral sclerosis (implicated_via_orthology)

TARDBP TAF15

1.19e-0430162DOID:332 (implicated_via_orthology)
DiseaseHVA measurement, 5-HIAA measurement

NCOA2 CREBBP

2.02e-0439162EFO_0005131, EFO_0005132
Diseasealcohol consumption measurement

NCOA2 NFAT5 ZFHX3 BNIP3L COMMD7

3.88e-041242165EFO_0007878
DiseaseAmyotrophic Lateral Sclerosis

TARDBP TAF15

4.48e-0458162C0002736
DiseaseCCL5 measurement

TAF15 KCNA4

5.45e-0464162EFO_0005117
Diseaseacute myeloid leukemia (is_implicated_in)

NCOA2 CREBBP

9.36e-0484162DOID:9119 (is_implicated_in)
Diseasecreatinine measurement

NFAT5 PRRC2C ZFHX3 COMMD7

1.69e-03995164EFO_0004518
Diseasetotal blood protein measurement

NCOA2 TARDBP RRBP1

1.69e-03449163EFO_0004536
Diseasealkaline phosphatase measurement

NCOA2 NFAT5 YAP1 RRBP1

1.82e-031015164EFO_0004533
Diseasereticulocyte count

YAP1 TAF15 BNIP3L KCNA4

2.02e-031045164EFO_0007986
Diseasetea consumption measurement

NFAT5 ZFHX3

2.19e-03129162EFO_0010091
Diseaselung non-small cell carcinoma (is_implicated_in)

NCOA2 ZFHX3

2.53e-03139162DOID:3908 (is_implicated_in)
Diseaseneurodegenerative disease (implicated_via_orthology)

TARDBP YAP1

2.75e-03145162DOID:1289 (implicated_via_orthology)
DiseaseQT interval

NCOA2 CREBBP ZFHX3

2.77e-03534163EFO_0004682
Diseasecolorectal cancer (is_marker_for)

YAP1 ZFHX3

3.21e-03157162DOID:9256 (is_marker_for)
DiseaseDisease Exacerbation

YAP1 TAF15

3.54e-03165162C0235874
Diseasecardioembolic stroke

ZFHX3 KCNA4

3.76e-03170162EFO_1001976
DiseaseProstatic Neoplasms

NCOA2 CREBBP ZFHX3

4.14e-03616163C0033578
DiseaseMalignant neoplasm of prostate

NCOA2 CREBBP ZFHX3

4.14e-03616163C0376358
Diseaseheart failure

NFAT5 ZFHX3

4.43e-03185162EFO_0003144
Diseasecortical surface area measurement

NCOA2 PRRC2C ZFHX3 AGAP3

5.04e-031345164EFO_0010736
Diseaseapolipoprotein B measurement

ZFHX3 KCNA4 RRBP1

5.08e-03663163EFO_0004615
Diseasepulse pressure measurement

NFAT5 YAP1 ZFHX3 COMMD7

5.69e-031392164EFO_0005763

Protein segments in the cluster

PeptideGeneStartEntry
MNFQAGGGQSPQQQQ

AGAP3

1

Q96P47
QQQQQQGSAGMAGGM

CREBBP

2211

Q92793
QGQQQNMESSGSQGG

TAF15

86

Q92804
SGTQQQGNGLFQQGN

NFAT5

1036

O94916
GNGGAQSQHQNVNQG

BCL9L

51

Q86UU0
MNSSNGNDNGNGKNG

BNIP3L

41

O60238
GGDMQQLNQLGAQQF

COMMD7

16

Q86VX2
GGQAVQVQGQQGQTQ

NFYA

116

P23511
SAIGQNMGNQNGNPT

TNRC6C

131

Q9HCJ0
QSGPSGNNQNQGNMQ

TARDBP

346

Q13148
QGGQGDGIQVNSQFQ

PRRC2C

126

Q9Y520
GNQGMIGNQGNLGNS

NCOA2

921

Q15596
QNQGQKGEGAQNQGK

RRBP1

506

Q9P2E9
QGGVMGGSNSNQQQQ

YAP1

291

P46937
LNNMQNLQNGGGEQV

ZFHX3

751

Q15911
TDLAQQQGGGNGQQQ

KCNA4

421

P22459
QQGGGNGQQQQAMSF

KCNA4

426

P22459